Currently Viewing:
Managed Care Cast

Examining Variation in Orphan Drug Coverage Among Commercial Plans

This month’s issue of The American Journal of Managed Care® took a look at differences in coverage of orphan and nonorphan drugs to get insight into variation in orphan drug coverage across the largest commercial plans in the United States. To get more insight into the findings, and the reasons behind these trends, we sat down with James Chambers, PhD, associate professor of medicine at Tufts Medical Center Institute for Clinical Research and Health Policy Studies.
This month’s issue of The American Journal of Managed Care® took a look at differences in coverage of orphan and nonorphan drugs to get insight into variation in orphan drug coverage across the largest commercial plans in the United States. The study, Variation in US Private Health Plans’ Coverage of Orphan Drugs, analyzed a data set of private health plan coverage decisions for specialty drugs in 3 ways and found that health plans restrict access to orphan drugs about one-third of the time and that restrictions vary across plans.

To get more insight into the findings, and the reasons behind these trends, we sat down with James Chambers, PhD, associate professor of medicine at Tufts Medical Center Institute for Clinical Research and Health Policy Studies.

 

Listen above or through one of these podcast services:

iTunes

TuneIn

Stitcher

Spotify

 
Copyright AJMC 2006-2019 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up